Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis

Abstract

Aim: To determine whether the use of low molecular weight heparin (LMWH) improves the pregnancy outcomes in women with inherited thrombophilia by conducting a meta-analysis of randomized controlled trials and observational studies. Methods: A systematic literature search of several databases was conducted through September 19, 2020 to identify relevant studies. The outcomes of interest included live birth and adverse pregnancy outcomes (APOs). The overall risk estimates were pooled using random-effects meta-analysis. Results: Ten randomized controlled trials and 12 cohort studies were included. In the meta-analyses of randomized controlled trials, the effectiveness of LMWH-treatment was found to be statistically significant in decreasing the risk of APOs (risk ratio [RR] = 0.76; 95% confidence interval [CI]: 0.61-0.95; p = 0.020), rather than in increasing the rate of live birth (RR = 1.12; 95% CI: 0.93-1.34; p = 0.230). In the meta-analyses of cohort studies, results showed that the use of LMWH was associated with a significantly higher proportion of live birth (RR = 1.86; 95% CI: 1.09-3.19; p = 0.020) as well as a significantly lower ratio of APOs (RR = 0.46; 95% CI: 0.31-0.69; p < 0.001) in women with inherited thrombophilia. Conclusions: The use of LMWH may have a potentially beneficial effect on reducing the risk of APOs and even increasing the live birth rate in women with inherited thrombophilia. Further well-designed clinical trials with large samples are needed to address the role of LMWH in improving pregnancy outcomes among pregnant women with inherited thrombophilia.

Impact of Thrombophilic Polymorphisms in Antenatal Women on Perinatal Health: A Single-Center Prospective Study

“…Thrombophilia-induced clotting disorders may partly result from thrombosis in the spiral artery and intervillous spaces of the maternal placenta, as well as inhibition of extra-villous trophoblast differentiation, avoiding essential placental tissue perfusion for fetal growth. Meta-analyses of case-control studies consistently highlight associations between inherited thrombophilias and late pregnancy complications like IUD, FGR, placental abruption, and PE [55,56]. On this regard, a Serbian study demonstrated better perinatal outcomes in women with hereditary thrombophilias treated with prophylactic LMWH, compared to untreated women [57], consistent with another research study [58].…”

Impact of Inherited Thrombophilia in Women with Obstetric Antiphospholipid Syndrome: A Single-Center Study and Literature Review

“…An interesting finding of our study is that women who did not receive treatment and presented an associated IT had a poorer prognosis concerning the most important outcome, which is a live newborn. In this regard, again, there are conflicting results in the literature on the impact of IT on obstetric outcomes [ 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. Noteworthy, when given adequate treatment, the prognosis was similar to that of patients without IT, and this was especially true in the group of patients with IT and those in whom the symptoms and/or the serological profile are not very conclusive.…”